Biotechs cross-over from private to public markets

摘要

Biotechs took centre stage in US ECM this past week with seven companies debuting, most in spectacular fashion. avrobio, a company focused on gene editing, posted a 64% day-one gain Thursday, despite a development pipeline that has advanced only to Phase I.